SCHEMBL11962346

SCHEMBL11962346

Cc1ccc2ccc3ccc(-c4ccc(Oc5ccc(-c6ccc7ccc8ccc(C)cc8c7n6)cc5)cc4)nc3c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.38
MAPT P10636 6/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2A6 P11509 2/20 0.36
KDM4E B2RXH2 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
ALDH1A1 P00352 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
EGFR P00533 1/20 0.36
KDR P35968 1/20 0.36
PKM P14618 1/20 0.35
PTGS1 P23219 1/20 0.34
TEAD4 Q15561 1/20 0.34
MEN1 O00255 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10032344 0.90 CYP1A2 (0.42) MAPTSMN1; SMN2CYP1A2CYP2A6KDM4E
SCHEMBL10032359 0.89 CYP1A2 (0.41) MAPTSMN1; SMN2CYP1A2CYP2A6KDM4E
SCHEMBL11962281 0.85 TEAD4 (0.44) PARP1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL10032376 0.82 CYP2A6 (0.43) SMN1; SMN2CYP1A2CYP2A6KDM4EALDH1A1
SCHEMBL10032479 0.81 ALDH1A1 (0.44) MAPTCYP1A2CYP2A6KDM4ENPC1
SCHEMBL10032396 0.81 ENPP3 (0.44) PARP1MAPTCYP1A2CYP2A6KDM4E
SCHEMBL10032409 0.81 ENPP3 (0.44) PARP1MAPTCYP1A2CYP2A6KDM4E
SCHEMBL11962344 0.81 KDM4E (0.42) MAPTSMN1; SMN2CYP1A2CYP2A6KDM4E
SCHEMBL10032384 0.80 ENPP3 (0.41) MAPTSMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL10032360 0.80 ENPP3 (0.41) MAPTSMN1; SMN2KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9054319-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-06-09 US disclosed
US-9054319-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-06-09 US disclosed
US-8759819-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-06-24 US disclosed
US-8759819-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-06-24 US disclosed
US-20140131680-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-05-15 US disclosed
US-20140131680-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-05-15 US disclosed
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. 2012-08-09 US disclosed
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. 2012-08-09 US disclosed
US-20100283043-A1 ORGANIC EL ELEMENT IDEMITSU LOSAN CO., LTD. 2010-11-11 US disclosed
US-20100283043-A1 ORGANIC EL ELEMENT IDEMITSU LOSAN CO., LTD. 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FTO, EML4, SLC43A1 PARP1 2955/4885MAPT 237/4885SMN1; SMN2 4079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.